Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $0.59 million for the quarter.
Guided Therapeutics Trading Down 4.1%
GTHP stock traded down $0.01 during trading on Wednesday, reaching $0.22. 8,246 shares of the stock were exchanged, compared to its average volume of 16,659. The firm’s 50 day moving average is $0.34 and its 200 day moving average is $0.31. The firm has a market cap of $20.40 million, a P/E ratio of -4.41 and a beta of 0.57. Guided Therapeutics has a twelve month low of $0.06 and a twelve month high of $0.54.
About Guided Therapeutics
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non?invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Featured Stories
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
